{"data":[{"accessionNo":"0000945621-26-000352","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting Common Shares, no par value","eventDate":"2025-12-31","reportingPerson":"Cooperman Leon G.","reportingCik":null,"personType":"IN","sharesOwned":3450000,"percentOfClass":6.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000919574-26-001133","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting common shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"John Fichthorn","reportingCik":null,"personType":"HC,IN","sharesOwned":153983,"percentOfClass":0.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000919574-26-001133","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting common shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Dialectic LS Manager LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000919574-26-001133","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting common shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Dialectic Capital Management, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000919574-26-001133","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting common shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Dialectic Partners, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000919574-26-001133","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting common shares, no par value per share","eventDate":"2025-12-31","reportingPerson":"Dialectic Life Sciences SPV LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0001104659-26-011569","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Common Shares, no par value","eventDate":"2025-12-31","reportingPerson":"TRILL AB","reportingCik":null,"personType":"FI","sharesOwned":8825742,"percentOfClass":16.9,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0001104659-26-011569","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Common Shares, no par value","eventDate":"2025-12-31","reportingPerson":"Jan Stahlberg","reportingCik":null,"personType":"IN","sharesOwned":8825742,"percentOfClass":16.9,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0001193125-25-272616","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting Common Shares, no par value","eventDate":"2025-09-30","reportingPerson":"Richard Jacinto II","reportingCik":null,"personType":"IN","sharesOwned":4958823,"percentOfClass":9.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"},{"accessionNo":"0000945621-25-000973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001401040","issuerName":"DiaMedica Therapeutics Inc.","ticker":"DMAC","cusip":null,"securityClass":"Voting Common Shares, no par value","eventDate":"2025-09-30","reportingPerson":"Cooperman Leon G.","reportingCik":null,"personType":"IN","sharesOwned":3269761,"percentOfClass":6.3,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/dmac"}],"updatedAt":"2026-11-03T19:27:49.217Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/dmac","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}